Work

Translational modelling challenges receptor‑occupancy‑based dosing of PD‑1 inhibitors like pembrolizumab

Year: 2026

Type: article

Source: British Journal of Cancer

DOI: 10.1038/s41416-026-03612-w

Authors: Judith D. J. Verdonk, Leila-Sophie Otten, Ghazal Montaseri, Michel M. van den Heuvel, Ruben L. Smeets, Hans J. P. M. Koenen, Rob ter Heine

Institutions: Radboud University Nijmegen, Radboud University Medical Center, Boehringer Ingelheim (Germany), University Medical Center Utrecht

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7208832510

FWCI:

Cites: 34

Cited by:

Related to: